The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Verona Pharma Plc ADR shares valued at $1,076,755 were sold by ZACCARDELLI DAVID on Oct 18 ’24. At $4.38 per share, ZACCARDELLI DAVID sold 245,784 shares. The insider’s holdings dropped to 15,004,920 shares worth approximately $516.62 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, ZACCARDELLI DAVID sold 157,912 shares, netting a total of over 692,728 in proceeds. Following the sale of shares at $4.39 each, the insider now holds 14,736,552 shares.
Before that, ZACCARDELLI DAVID had sold 110,456 shares from its account. In a trade valued at $483,753, the President and CEO traded Verona Pharma Plc ADR shares for $4.38 each. Upon closing the transaction, the insider’s holdings decreased to 110,456 shares, worth approximately $512.82 million.
As published in their initiating research note from Wells Fargo on October 03, 2024, Verona Pharma Plc ADR [VRNA] has been an Overweight and the price target has been revised to $50. Earlier on August 26, 2022, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for VRNA stock.
Analyzing VRNA Stock Performance
During the last five days, there has been a drop of approximately -0.66%. Over the course of the year, Verona Pharma Plc ADR shares have jumped approximately 73.19%. Shares of the company reached a 52-week high of $35.62 on 10/22/24 and a 52-week low of $11.39 on 05/30/24. A 50-day SMA is recorded $29.83, while a 200-day SMA reached $20.12. Nevertheless, trading volume fell to 0.6 million shares from 1.1 million shares the previous day.
Support And Resistance Levels for Verona Pharma Plc ADR (VRNA)
According to the 24-hour chart, there is a support level at 34.14, which, if violated, would cause prices to drop to 33.85. In the upper region, resistance lies at 34.96. The next price resistance is at 35.50. RSI (Relative Strength Index) is 68.89 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.14, which suggests the price will increase in the coming days. Percent R is at 26.27%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
Which companies own the most shares of Verona Pharma Plc ADR (VRNA)?
On September 13, 2021, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $25.
